These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 15302139)

  • 1. Intracellular metabolism and pharmacokinetics of 5'-hydrogenphosphonate of 3'-azido-2',3'-dideoxythymidine, a prodrug of 3'-azido-2',3'-dideoxythymidine.
    Skoblov Y; Karpenko I; Shirokova E; Popov K; Andronova V; Galegov G; Kukhanova M
    Antiviral Res; 2004 Aug; 63(2):107-13. PubMed ID: 15302139
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of the activation pathway of phosphoramidate triester prodrugs of stavudine and zidovudine.
    Saboulard D; Naesens L; Cahard D; Salgado A; Pathirana R; Velazquez S; McGuigan C; De Clercq E; Balzarini J
    Mol Pharmacol; 1999 Oct; 56(4):693-704. PubMed ID: 10496951
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intracellular metabolism of CycloSaligenyl 3'-azido-2', 3'-dideoxythymidine monophosphate, a prodrug of 3'-azido-2', 3'-dideoxythymidine (zidovudine).
    Balzarini J; Naesens L; Aquaro S; Knispel T; Perno C; De Clercq E; Meier C
    Mol Pharmacol; 1999 Dec; 56(6):1354-61. PubMed ID: 10570065
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro and in vivo pharmacokinetic characterization of two novel prodrugs of zidovudine.
    Quevedo MA; Briñón MC
    Antiviral Res; 2009 Aug; 83(2):103-11. PubMed ID: 19549583
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetics of bis(t-butyl-SATE)-AZTMP, a bispivaloylthioethyl prodrug for intracellular delivery of zidovudine monophosphate, in mice.
    Tan X; Boudinot FD; Chu CK; Egron D; Perigaud C; Gosselin G; Imbach JL
    Antivir Chem Chemother; 2000 May; 11(3):203-11. PubMed ID: 10901291
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetics and tissue distribution of (+/-)-3'-azido-2',3'-dideoxy-5'-O-(2-bromomyristoyl)thymidine, a prodrug of 3'-azido-2',3'-dideoxythymidine (AZT) in mice.
    Parang K; Wiebe LI; Knaus EE
    J Pharm Pharmacol; 1998 Sep; 50(9):989-96. PubMed ID: 9811159
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transplacental pharmacokinetics and fetal distribution of azidothymidine, its glucuronide, and phosphorylated metabolites in late-term rhesus macaques after maternal infusion.
    Patterson TA; Binienda ZK; Lipe GW; Gillam MP; Slikker W; Sandberg JA
    Drug Metab Dispos; 1997 Apr; 25(4):453-9. PubMed ID: 9107545
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis, in vitro and in vivo release kinetics, and anti-HIV activity of a sustained-release prodrug (mPEG-AZT) of 3'-azido-3'-deoxythymidine (AZT, Zidovudine).
    Li W; Chang Y; Zhan P; Zhang N; Liu X; Pannecouque C; De Clercq E
    ChemMedChem; 2010 Nov; 5(11):1893-8. PubMed ID: 20936623
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Potentiating AZT activation: structures of wild-type and mutant human thymidylate kinase suggest reasons for the mutants' improved kinetics with the HIV prodrug metabolite AZTMP.
    Ostermann N; Lavie A; Padiyar S; Brundiers R; Veit T; Reinstein J; Goody RS; Konrad M; Schlichting I
    J Mol Biol; 2000 Nov; 304(1):43-53. PubMed ID: 11071809
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A method for quantitating the intracellular metabolism of AZT amino acid phosphoramidate pronucleotides by capillary high-performance liquid chromatography-electrospray ionization mass spectrometry.
    Kim J; Park S; Tretyakova NY; Wagner CR
    Mol Pharm; 2005; 2(3):233-41. PubMed ID: 15934784
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vivo biodistribution, pharmacokinetic parameters, and brain uptake of 5-halo-y-methoxy(or ethoxy)-5,6-dihydro-3'-azido-3'-deoxythymidine diastereomers as potential prodrugs of 3'-azido-3'-deoxythymidine.
    Wang L; Morin KW; Kumar R; Cheraghali M; Todd KG; Baker GB; Knaus EE; Wiebe LI
    J Med Chem; 1996 Feb; 39(4):826-33. PubMed ID: 8632406
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Brain targeting of anti-HIV nucleosides: synthesis and in vitro and in vivo studies of dihydropyridine derivatives of 3'-azido-2',3'-dideoxyuridine and 3'-azido-3'-deoxythymidine.
    Chu CK; Bhadti VS; Doshi KJ; Etse JT; Gallo JM; Boudinot FD; Schinazi RF
    J Med Chem; 1990 Aug; 33(8):2188-92. PubMed ID: 2374145
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Decomposition of 3'-azido-2',3'-dideoxythymidine 5'-monophosphate (AZTMP) prodrugs in biological media studied by on-line solid-phase extraction coupled to liquid chromatography mass spectrometry.
    Lefebvre I; Beltran T; Peyrottes S; Périgaud C
    Biomed Chromatogr; 2009 Nov; 23(11):1160-8. PubMed ID: 19444806
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Disposition and oral bioavailability in rats of an antiviral and antitumor amino acid phosphoramidate prodrug of AZT-monophosphate.
    Song H; Johns R; Griesgraber GW; Wagner CR; Zimmerman CL
    Pharm Res; 2003 Mar; 20(3):448-51. PubMed ID: 12669967
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Novel approaches for designing 5'-O-ester prodrugs of 3'-azido-2', 3'-dideoxythymidine (AZT).
    Parang K; Wiebe LI; Knaus EE
    Curr Med Chem; 2000 Oct; 7(10):995-1039. PubMed ID: 10911016
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Adducts of 3'-azido-2,3'-dideoxythymidine 5'-phosphate or 5'-phosphonate as inhibitors of cytopathic effect and transformation of cells under the influence of retroviruses in cell culture].
    Fedorov II; Kraevskiĭ AA; Bal'zarinin Zh; De Klerk E
    Mol Biol (Mosk); 1992; 26(5):1122-7. PubMed ID: 1470177
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cellular metabolism of 3'-azido-2',3'-dideoxyuridine with formation of 5'-O-diphosphohexose derivatives by previously unrecognized metabolic pathways for 2'-deoxyuridine analogs.
    Zhu Z; Schinazi RF; Chu CK; Williams GJ; Colby CB; Sommadossi JP
    Mol Pharmacol; 1990 Dec; 38(6):929-38. PubMed ID: 2250666
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Self-assembled drug delivery systems. Part 4. In vitro/in vivo studies of the self-assemblies of cholesteryl-phosphonyl zidovudine.
    Jin Y; Xing L; Tian Y; Li M; Gao C; Du L; Dong J; Chen H
    Int J Pharm; 2009 Oct; 381(1):40-8. PubMed ID: 19646518
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phase I dose-escalation pharmacokinetics of AZT-P-ddI (IVX-E-59) in patients with human immunodeficiency virus.
    Zhou XJ; Squires K; Pan-Zhou XR; Bernhard S; Agrofoglio L; Kirk M; Duchin KL; Sommadossi JP
    J Clin Pharmacol; 1997 Mar; 37(3):201-13. PubMed ID: 9089422
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro and in vivo pharmacokinetic features and metabolism of the novel cytotoxic nucleoside analog 3'-azidothymidine 5'-[p-methoxyphenyl methoxyalaninyl phosphate] (Compound 003).
    Uckun FM; Chen CL; Liu XP; Dibirdik I; Venkatachalam TK
    Arzneimittelforschung; 2004; 54(11):732-45. PubMed ID: 15612614
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.